Top Tweets for #GPC3
New patent application #US20260191905A1 by #ModernaTX reveals
anti-Glypican 3 (#GPC3) antibodies & binding proteins.
Includes nucleic acids encoding these proteins.
Methods for treating diseases like cancer (e.g., HCC) are detailed.
#Healthcare #Biotech $MRNA #PatentApplication
#OnlineFirst: Identification and Non-clinical Characterization of SAR444200, a Novel Anti-GPC3 #NANOBODY® T-cell Engager, for the Treatment of #GPC3+ #SolidTumors https://t.co/yY6fcatHz9
@sanofi #FirstDisclosure #TCellEngager #OpenAccess
Article✍️#GPC3-mediated #lysosome-targeting chimeras (#GLTACs) for targeted #degradation of membrane #proteins. From Dr. Sheng @NavalMedicalUniversity; @ELSpharma.
https://t.co/kBWWkOMMVv.
#CellTherapy with C-CAR031 coming into #HCC in #ASCO24
🧬#GPC3 CAR-T
👍74% partial responses at DL4
👉90% with tumour reduction
🙌🏻good safety profile
🤔24/87 treated
🤞🏻🤞🏻🤞🏻🤞🏻🤞🏻🤞🏻🤞🏻
@myESMO @_SEOM @GrupoTTD @VicMorenoGarcia @EASLnews
very happy to see that also other research groups follow up on our hypothesis that #FOXA2 is a yolk-sac tumor #biomarker and outperformes #AFP and #GPC3...
Published recently @Histo_Journal
#pathology #urology #Cancer #testiscancer
https://t.co/EPgzAFSafG
Tech for early primary #livercancer dx is needed. A radiolabeled glypican-3 targeting antibody detected miniscule #HCC tumors in mice w/ high reproducibility. This tech may improve dx and tx for #HCC! https://t.co/sXqQwOkaoH #immunoPET #GPC3 #dosresearch @UWHPBSurgery
Cytovia Therapeutics R&D Team Publishes Preclinical Data for its #GPC3-Targeted Flex-NK™ Bispecific #Antibody for #HCC in the @Cells_MDPI Journal
Read more about how these results warrant clinical investigation of our CYT-303 antibody below:
https://t.co/OTlCESVVJP
3- GPC3
Glypican-3 is a cell surface protein that plays a role in the development and progression of various types of cancer, including hepatocellular carcinoma (HCC). Companies such as Carsgen, Takeda, Legend Biotech and AstraZeneca are developing CAR-T programs targeting #GPC3
Cytovia Presents New Preclinical Data for Its GPC3 Flex-NK™ Cell Engager Antibody in Combination With NK Cells at ESMO 2022
Read More: https://t.co/dR2ZTT0vin
Link to Poster: https://t.co/9VVJwZQCKn
#CellTherapy #NKCells #iPSC #GeneEditing #Antibodies #GPC3 #HCC #esmo22
We are excited to announce that @EurekaThera and @cityofhope have treated the first patient with #GPC3 targeting ARTEMIS® T Cells (ECT204) for Advanced #livercancer! Read more: https://t.co/CN1lWLnT19
Cytovia Therapeutics Presents at AACR Special Conference on Advances in the Pathogenesis and Molecular Therapies of Liver Cancer
Read More: https://t.co/vvxPKqIGzH
#CellTherapy #ImmunoTherapy #Oncology #NKCells #iPSC #StemCells #GeneEditing #Antibodies #GPC3 #HCC #LiverCancer
Watch Cytovia's CMO Stanley Frankel discuss our pipeline and its focus on applying our iNK & Flex-NK™ technologies towards key unmet medical needs, starting with our #GPC3 program for #HCC
https://t.co/65VF37vlfY
#NKCells #Antibodies #CellTherapy #ImmunoTherapy #LiverCancer
#PierisPharmaceuticals and #BostonPharmaceuticals Enter into an Exclusive Worldwide Product License for #PRS342, a #41BB #GPC3 #ImmunoOncology #Bispecific $PIRS https://t.co/0an1LKYnso
We look forward to the advancement of PRS-342, a 4-1BB/GPC3 bispecific, by @BosPharma and to directly supporting some crucial next steps towards clinical initiation. Learn more about the agreement here: https://t.co/uE6zCEl2e4 #improvinglives
[Publication] Prof. Toutain - CUGC pour le syndrome Simpson-Golabi-Behmel https://t.co/mskrowjbl0 #Tours #iBrain #UMR1253 #GPC3 #Simpson_Golabi_Behmel_syndrome @ScienceNews @lemonde_science @Sciences_Avenir @science_actus @NYTScience @sciencebeta @ms_MedSci @science_et_vie
![iBrain_Inserm's tweet photo. [Publication] Prof. Toutain - CUGC pour le syndrome Simpson-Golabi-Behmel https://t.co/mskrowjbl0 #Tours #iBrain #UMR1253 #GPC3 #Simpson_Golabi_Behmel_syndrome @ScienceNews @lemonde_science @Sciences_Avenir @science_actus @NYTScience @sciencebeta @ms_MedSci @science_et_vie https://t.co/F8rOjh3XTJ](https://pbs.twimg.com/media/DypZzabX4AUM9-c.jpg)
[Publication] Prof. Toutain - CUGC for Simpson-Golabi-Behmel syndrome https://t.co/igeG8Z4LUz #Tours #iBrain #UMR1253 #GPC3 #Simpson_Golabi_Behmel_syndrome @UnivTours @FacmedTours @InsermGrdOuest @Inserm @CHRU_Tours @ARS_CVDL @HUGrandOuest @RESEAUCHU @Allodocteurs @prioritesante
![iBrain_Inserm's tweet photo. [Publication] Prof. Toutain - CUGC for Simpson-Golabi-Behmel syndrome https://t.co/igeG8Z4LUz #Tours #iBrain #UMR1253 #GPC3 #Simpson_Golabi_Behmel_syndrome @UnivTours @FacmedTours @InsermGrdOuest @Inserm @CHRU_Tours @ARS_CVDL @HUGrandOuest @RESEAUCHU @Allodocteurs @prioritesante https://t.co/OheHtZizsY](https://pbs.twimg.com/media/DypZDctW0AI0Rqz.jpg)
Last Seen Hashtags on Sotwe
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.9M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Cristiano Ronaldo
@cristiano
111.6M followers
Narendra Modi
@narendramodi
107.1M followers
Rihanna
@rihanna
97.9M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.1M followers
KATY PERRY
@katyperry
88.2M followers
Taylor Swift
@taylorswift13
82M followers
Lady Gaga
@ladygaga
73.6M followers
Virat Kohli
@imvkohli
70.7M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.2M followers
Neymar Jr
@neymarjr
63.6M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61.3M followers
X
@x
60.8M followers